We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Incagold | LSE:IGD | London | Ordinary Share | GB00B08CJ115 | ORD 0.001P |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.00 | 0.00% | 0.40 | - | 0.00 | 01:00:00 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
0 | 0 | N/A | 0 |
Date | Subject | Author | Discuss |
---|---|---|---|
10/3/2010 20:52 | ...looks like we could see some action here tomorrow...possible decks being cleared for new ceo in marketing...hmmmmmmm | pre | |
10/3/2010 20:34 | WATHCHERS USE THE NEW THREAD AS THIS WILL BE FILLED WITH BASHERS WITH NO INTEREST IM AFRAID I CANNOT MODERATE PREMIUM USERS | buystock | |
10/3/2010 19:44 | sorry buystock but you have that wrong, i am using the same and only screen name which is the same on every board (lse@iii). As i said earlier i am in this but with only half a mil with an average of .033 as i bought a few weeks ago but topped up today another 130k or thereabouts (about £330).just looking at it from all angles and worried the insurance man has gone. | wathchers | |
10/3/2010 19:43 | Roy Tilleard has extensive international experience in many industries in both multinational and private business. A qualified accountant Roy Tilleard spent almost 20 years working for Unilever Plc in various locations including three years based in Hamburg before leaving to start his own industrial chemicals business. This he sold in 1990 and subsequently completed a buy out of the Deb Group, best known for Swarfega. Roy Tilleard and his business partner sold around half of the Deb Group to Barclays Private Equity in March 2004 in a £135 million transaction and subsequently sold his remaining holding in December 2006. Roy Tilleard is the Chairman and Chief Executive of AIM listed Kurawood PLC and Non-executive Chairman of IncaGold plc and a director of Lorne House Family Office. He also involved in both residential and commercial property development through his business Callows Yard Developments Ltd. Significant shareholdings: Fox Capital Limited 80.20% Daniel Aurell 6.01% Pershing Keen Nominees 4.77% As at 23 December 2009 the Company had issued 449,255,459 ordinary shares of 0.001p each. No shares are held in treasury. | buystock | |
10/3/2010 19:39 | WATCHOUT2/WATCHERS/8 | buystock | |
10/3/2010 19:34 | Cosmetic surgery is booming in Britain Cosmetic surgery is becoming more and more popular in the UK, with increasing numbers of women and men opting to improve their looks by going under the surgeon's knife. Last year alone an estimated 90,000 people underwent a cosmetic operation - a staggering 30 per cent rise on the previous 12 months. But while most patients are satisfied with their surgery, more and more are finding that not all operations go to plan. They are left counting not only the financial cost of disappointing results, but also the emotional and physical cost of painful injuries, prolonged suffering and trauma when their cosmetic surgery goes wrong. At TJL Solicitors, we understand that no amount of money could possibly compensate for the suffering caused by poor cosmetic surgery. However, our experts believe they can help patients recover both their physical well being and self esteem, by securing the funds they need for corrective surgery and helping them get their lives back on track. We also hope that by bringing these cases to court we can raise awareness among other patients similarly affected to help improve medical standards and treatment.Following the divestiture, the Directors believe that the Company could be attractive to a number of potential targets/investments. The Directors intend to seek to acquire another company or business in exchange for the issue of Ordinary Shares in a single transaction (a "reverse takeover"). The Directors' main investment criteria are: - * businesses in the UK, Europe and North America; * businesses which require little or no funding in excess of the cash resources available to the Company following the Disposal; and * businesses whose growth prospects, if achieved, will be earnings enhancing for Shareholders DIRECTOR COMPANIES Mike Evans (64), Director Roy W. Tilleard ~ Chairman Born 1947. Roy Tilleard has extensive international experience in many industries in both multinational and private business. A qualified accountant, he spent almost 20 years working for Unilever Plc in various locations including 3 years based in Hamburg before leaving to start his own industrial chemicals business. This he sold in 1990, completing a buy out of the Deb Group (best known for "Swarfega"), which was subsequently sold to Barclays Private Equity in 2004. With his business partner, Justin Martin, Roy also founded Fox Capital, a private equity business. He is Chairman and Chief Executive of the AIM-listed company, Kurawood PLC and chairman of IncaGold PLC. Through his commercial and residential property business, Callows Yard Developments Limited, Roy has also undertaken the restoration of a significant number of commercial and residential properties in the heart of Castletown. Roy was appointed as Chairman of Lorne House Trust Limited in June 2007 Justin Martin has spent the last 15 years in finance, business and product development, managing numerous businesses in the Isle of Man, the United Kingdom and the Russian Federation. Justin Martin began his career as the Finance and Administration Director for a Moscow based subsidiary of Universal Leaf Tobacco Corporation, and previous to this was the Deputy Financial Director for the Moscow based restaurant and electronics importer JSC Rosinter. In the mid 90's Justin Martin co-founded and operated the Moscow based arm of a UK stock-broking, asset management and corporate finance business, leaving Russia in 1998 to co-found Flintstone Technologies plc, the then AIM listed specialist investment company. During his tenure at Flintstone, the company raised over £40m in private equity, successfully launching and managing seven technology based companies, one of which, Hardide plc, was admitted to AIM in 2005. Currently Justin Martin serves as the Chief Financial Officer of AIM listed Kurawood plc and is a non-executive Director of IncaGold plc, the AIM listed specialist digital content publisher. up 25% on plus LINK PLUS MARKETS | buystock | |
10/3/2010 19:12 | but i read michael was brought on board as an insurance expert so surely he would be an asset if we was going to launch? seams odd to get rid of the insurance guy when thats the area your trying to break. Maybe the european insurance we was looking at has also fell through and now these will have to rethink there business? | wathchers | |
10/3/2010 17:36 | WONDER IF ROY,S CLEARING THE DECKS with a new ceo in marketing for the launch. | buystock | |
10/3/2010 17:23 | RNS Number : 4018I IncaGold Plc 10 March 2010 IncaGold plc (the "Company") Resignation of Director The Board announces the resignation of Michael Evans as a director of the Company with immediate effect. | buystock | |
10/3/2010 17:18 | and here,s why its a massive niche market.British cosmetic surgery is an 'unregulated mess', say surgeons British cosmetic surgery is an "unregulated mess" according to a group of leading doctors. By Urmee Khan Published: 12:52AM GMT 16 Nov 2009 The doctors, who include leading consultant plastic surgeons and medical regulators, have warned that greed and increased marketing threatened patients safety, and have called for a regulator to tackle increasingly poor practice. Nigel Mercer, president of the British Association of Aesthetic Plastic Surgeons, said that drastic action had to be taken to control standards. Related Articles Ex-Miss Argentina dies after operation to tone buttocks NHS pays for botched cosmetic surgery abroad, warn surgeons Obesity leads to rise in cosmetic surgery to reduce flabby skin British surgeons should hypnotise patients for some operations, says academic Rise in breast surgery for brides seeking a wedding day boost Girl with webbed hands has fingers separated by doctors in ChinaWriting in a paper published today in Clinical Risk, the journal of the Royal Society of Medicine, Mr Mercer states: "We have reached a stage where public expectation, driven by media hype and, dare one say, professional greed, has brought us to a 'perfect storm' in the cosmetic surgical market." The number of official cosmetic surgical has more than tripled to 34,000 since 2003, with tummy tucks, breast augmentation, and nose jobs among the most popular. However, many procedures are also carried out on the black market. Mr Mercer describes the proliferation of promotional marketing, including discount vouchers, two-for-one offers and holidays with surgery, which would be outlawed in any other area of medicine. "Imagine a 'two-for-one' advert for general surgery. That way lies madness," he writes. "All cosmetic treatments are medical interventions, and every medical intervention has a complication and failure rate. Consequently, there are no 'consumers' or 'clients' but only 'patients'." "There is no overarching body that looks after cosmetic surgery in this country, Mr Mercer said, "It is an unregulated mess | buystock | |
10/3/2010 17:08 | These processes become very tempting for men as they pass through their 30's and begin to see the telltale signs of aging. Younger men who do not have the time or inclination to spend long sessions at the gym can get pectoral implants and leg enhancements to get the six-pack abs and muscular look if they are willing to brave the potential dangers of surgery. Generally any male with feelings of inadequacy about their physical looks are candidates for male plastic surgery. This seeming need for males to enhance their looks has grown into a $3.5 billion dollar a year industry. Doctors and surgical clinics are increasingly opening up to handle this demand. There is not a major city in the United States that does not sport at least one such operation. A quick online search will reveal not only the practitioners who perform these services, but also an idea of just how much the cost will | buystock | |
10/3/2010 16:55 | up 25% on plus | buystock | |
10/3/2010 16:40 | wathchers they are like all stocks you pay your money you take your chance just be happy your in this low i am and i dont care what bashers say these guys have sunk money into this thats why its 90% held they could have walked away they have not.its been a while coming but hey ho it could be 2morrow it could be next week but at least we have backers.buy on dips thats my motto forget the bull from bashers they have no interest in the stock.gl | buystock | |
10/3/2010 16:32 | BUYSTOCK How long before the launch though? i am in but with a modest half mil, would love to see 2-3p. i emailed them this morning and they aren't exactly speedy in replying back. | wathchers | |
10/3/2010 16:24 | pre every time it dips ill be getting more this has massive potential and 10% in free float watch the scramble when the website launches.possible 2-3p pronto | buystock | |
10/3/2010 15:22 | back up...news iminent here judging by the action...if they pull it off this could potentially multibag.. | pre | |
10/3/2010 15:20 | US Cosmetic Surgery Products Market Demand to grow more than 8% annually through 2012 Demand for cosmetic surgery products in the US is forecast to increase 8.1 percent per year to $2.5 billion in 2012, based on increases in cosmetic surgery procedures, which are forecast to reach 16 million over the same time period. America's obsession with a youthful appearance is longstanding, and is unlikely to subside anytime soon. This coupled with an aging population, a greater societal acceptance of cosmetic surgery, and an increasingly competitive work force will bode well for the cosmetic surgery industry. Due to much more busy lifestyles, less invasive cosmetic surgery procedures and products (such as injections, laser dermal resurfacing and microdermabrasion) that result in little or no recovery time will experience the best opportunities. However, demand for surgical products will continue to be strong in some areas, such as implants, where there are no notable alternatives. Lasers, microdermabrasion machines will offer steady equipment gains Equipment was the largest product type in 2007, with one-third of the market. Demand will be driven as a wider variety of practitioners are expected to increasingly offer cosmetic options as these procedures are generally "out-of-pocket" expenses and thus avoid the need to deal with insurance companies. The development of easier-to-use and safer equipment will also continue to open up strong opportunities in other end-users such as beauty salons and spas. Among equipment types, microdermabrasion machines and laser and other light-based systems will continue to achieve steady growth. | buystock | |
10/3/2010 15:17 | Will Insurance Cover the Cost of My Plastic Surgery? By Natalie Kita, About.com Guide Updated: March 10, 2009 About.com Health's Disease and Condition content is reviewed by the Medical Review Board .See More About:plastic surgery costsinsurance coverage of plastic surgery Sponsored Links Health Insurance Plans Compare Health Insurance. One Simple Form Gets You The Best Deal Health-Insurance.Usa Plastic Surgery Prices Find Affordable Clinics Compare & Get the Best Prices! ClinicCompare.co.uk/ Need Good Health Cover? Get Insurance From Only £10.20/mth. Quick Quotes & No Obligation. LookForHealth.co.uk Question: Will Insurance Cover the Cost of My Plastic Surgery? Answer: Many people want to know if their health insurance will cover the cost of their plastic surgery procedure. The answer is sometimes yes, but more often, no | buystock | |
10/3/2010 15:14 | 3v2 again pre 8trader/watchou2 feeble attempt not working at bashing 10% in free float and launch anytime soon this will become very popular.cosmetic insurance is a multi billion business that many insurers wont touch niche mkt/niche profits.gl | buystock | |
10/3/2010 14:31 | bye bye 8trade/watchout2 | buystock | |
10/3/2010 14:31 | bye bye 8trade/watchout2 | buystock | |
10/3/2010 13:31 | cheers buystock...now about to move up...looking good...won't take much buying to get this motoring given the level of free float...does look cheap, imo... | pre | |
10/3/2010 13:28 | up 50% on plus pre the link too the website which says it was coming soon is now not accessable is it about too go live.Coming Soon Surgisure is a new insurance solution to give you financial protection against the consequences of cosmetic surgery going wrong. ... . Company name - SURGISURE HEALTH INTERNATIONAL LIMITED . | buystock |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions